| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | 0.0096 | 0.8 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.0068 | 0.8 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.0064 | 0.8 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.8 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.0064 | 0.8 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.8 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.012 | 0.9 |